A Single-Center, Single-Dose, Randomized, Open-Label, Four-Period, Four-Treatment Crossover Study Evaluating Pharmacokinetic Properties Of Low-Dose SoluMatrix Meloxicam In Healthy Adults.
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Meloxicam (Primary) ; Meloxicam
- Indications Musculoskeletal pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Iroko Pharmaceuticals
Most Recent Events
- 25 Nov 2014 New trial record